Sedentary time and markers of inflammation in people with newly diagnosed type 2 diabetes
- PMID: 24925122
- PMCID: PMC4154448
- DOI: 10.1016/j.numecd.2014.03.009
Sedentary time and markers of inflammation in people with newly diagnosed type 2 diabetes
Abstract
Background and aims: We investigated whether objectively measured sedentary time was associated with markers of inflammation in adults with newly diagnosed type 2 diabetes.
Methods and results: We studied 285 adults (184 men, 101 women, mean age 59.0 ± 9.7) who had been recruited to the Early ACTivity in Diabetes (Early ACTID) randomised controlled trial. C-reactive protein (CRP), adiponectin, soluble intracellular adhesion molecule-1 (sICAM-1), interleukin-6 (IL-6), and accelerometer-determined sedentary time and moderate-vigorous physical activity (MVPA) were measured at baseline and after six-months. Linear regression analysis was used to investigate the independent cross-sectional and longitudinal associations of sedentary time with markers of inflammation. At baseline, associations between sedentary time and IL-6 were observed in men and women, an association that was attenuated following adjustment for waist circumference. After 6 months of follow-up, sedentary time was reduced by 0.4 ± 1.2 h per day in women, with the change in sedentary time predicting CRP at follow-up. Every hour decrease in sedentary time between baseline and six-months was associated with 24% (1, 48) lower CRP. No changes in sedentary time between baseline and 6 months were seen in men.
Conclusions: Higher sedentary time is associated with IL-6 in men and women with type 2 diabetes, and reducing sedentary time is associated with improved levels of CRP in women. Interventions to reduce sedentary time may help to reduce inflammation in women with type 2 diabetes.
Keywords: Breaks in sedentary time; Inflammation; Sedentary time; Type 2 diabetes.
Copyright © 2014 Elsevier B.V. All rights reserved.
References
-
- Chen L., Magliano D.J., Zimmet P.Z. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228–236. - PubMed
-
- Monesi L., Tettamanti M., Cortesi L., Baviera M., Marzona I., Avanzini F. Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: findings from an administrative database. Nutrition, metabolism, and cardiovascular diseases. Nutr Metab Cardiovasc Dis. 2014;24(3):263–270. - PubMed
-
- Williams M., Nadler J. Inflammatory mechanisms of diabetic complications. Curr Diab Rep. 2007/06/01;7(3):242–248. [in English] - PubMed
-
- Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. January 28, 2003;107(3):499–511. - PubMed
-
- Yu H.I., Sheu W.H.H., Song Y.M., Liu H.C., Lee W.J., Chen Y.T. C-reactive protein and risk factors for peripheral vascular disease in subjects with type 2 diabetes mellitus. Diabet Med. 2004;21(4):336–341. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
